TGFB1 and neoplasm: These findings establish that EMILIN-1′s tumor suppressor activity in gastrointestinal cancers operates through two distinct mechanisms: (1) integrin-dependent growth regulation via the gC1q domain and (2) TGF-β modulation through the EMI domain.